Large gap with delayed quotes
|
Last quote
04/25/2026
-
02:00:00
|
Bid
04/27/2026 -
14:41:28
|
Bid Volume |
Ask
04/27/2026 -
14:41:28
|
Ask Volume |
|---|---|---|---|---|
|
410.54
+17.12
(
+4.35% )
|
400.00
|
40 |
455.62
|
40 |
Analysis date: 24.04.2026
Global Evaluation
Negativ
Negativ
The stock is classified in the negative zone since 24.04.2026.
Interest
None
None
No stars since 24.04.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 14.04.2026 at a price of 520.00.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 24.04.2026.
4wk Rel Perf
-20.18%
-20.18%
The four-week dividend-adjusted underperformance versus SP500 is 20.18%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 23.01.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.11%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 4.73%.
Mkt Cap in $bn
11.72
11.72
With a market capitalization >$8bn, MEDPACE HOLDINGS is considered a large-cap stock.
G/PE Ratio
0.81
0.81
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
20.41
20.41
The estimated PE is for the year 2028.
LT Growth
16.44%
16.44%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
10
10
Over the last seven weeks, an average of 10 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
85
85
For 1% of index variation, the stock varies on average by 0.85%.
Correlation
0.16
0.16
Stock movements are totally independent of index variations.
Value at Risk
116.44
116.44
The value at risk is estimated at USD 116.44. The risk is therefore 28.36%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
27.11.2020
27.11.2020